Similar articles

• [Clinical evaluation of bone metastases from carcinoma of the digestive system by scintigraphy with 99mTc-phosphorous compounds (author's transl)].

  Bussaka H, Fujimura N. Bussaka H, et al. Kaku Igaku. 1981 Jun;18(5):591-9. Kaku Igaku. 1981. PMID: 7311128 Japanese. No abstract available.
• [Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. II. Comparison between bone scintigraphy and roentgenographic findings and their assessments (author's transl)].

  Fujimura N. Fujimura N. Nihon Igaku Hoshasen Gakkai Zasshi. 1979 Jun 25;39(6):627-36. Nihon Igaku Hoshasen Gakkai Zasshi. 1979. PMID: 482079 Japanese. No abstract available.
• [Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. III. The ability of detection by bone scintigraphy and roentgenography in bone destructed by Pancoast's tumor (author's transl)].

  Fujimura N. Fujimura N. Nihon Igaku Hoshasen Gakkai Zasshi. 1979 Sep;39(9):984-92. Nihon Igaku Hoshasen Gakkai Zasshi. 1979. PMID: 514803 Japanese. No abstract available.
• Which metabolic imaging, besides bone scan with 99mTc-phosphonates, for detecting and evaluating bone metastases in prostatic cancer patients? An open discussion.

  Bombardieri E, Setti L, Kirienko M, Antunovic L, Guglielmo P, Ciocia G. Bombardieri E, et al. Q J Nucl Med Mol Imaging. 2015 Dec;59(4):381-99. Epub 2015 Sep 3. Q J Nucl Med Mol Imaging. 2015. PMID: 26337240 Review.
• [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases].

  Bathmann J, Moser E. Bathmann J, et al. Radiologe. 1995 Jan;35(1):8-14. Radiologe. 1995. PMID: 7892445 Review. German.